Search
The Kids Research Institute Australia's annual report highlights the accomplishments of our researchers, furthering our mission to secure a happier, healthier future for kids everywhere.
View The Kids Research Institute Australia's 2025 Impact Report
Research
Ear InfectionsMiddle ear infections are one of the main reasons that children visit a GP, are prescribed antibiotics and need surgery. Aboriginal children are particularly susceptible and commonly suffer from hearing loss which can affect speech and learning.
News & Events
New tool guides families on RSV immunisationResearchers from the Wesfarmers Centre of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, have launched an online guidance tool designed to help families and health-care providers in WA learn the best way to protect babies and young children against life-threatening respiratory syncytial virus (RSV).
Research
Strep A (Group A Streptococcus)Streptococcus A is a bacterium often found in the throat and on the skin.
News & Events
Shot in the arm for Strep A vaccine bidThe Leducq Foundation has bolstered an Australian-led bid to develop a Strep A vaccine, committing USD4.3 million to fund critical scientific work.
News & Events
The Kids Research Institute Australia launches Covid-19 booster research to inform Australia’s vaccine policyOptimising our national Covid-19 vaccine program could be one step closer thanks to new research now underway at The Kids Research Institute Australia investigating the most effective, long-term strategies for booster vaccinations.
News & Events
Latest Deborah Lehmann Research Award recipient tackles malaria in MadangPapua New Guinean researcher Dr Lincoln Timinao has been awarded the 2025 Deborah Lehmann Research Award (DLRA) for his work aimed at investigating the burden of malaria in young children.
We encourage students to apply for scholarships to support their studies. Applications for non-university scholarships can be made through the Institute.
News & Events
Study which deliberately infected participants leads to penicillin breakthroughA unique study purposely giving participants Streptococcus pyogenes (Strep A) to learn how much penicillin it takes to prevent infection has found the amount needed is much lower than previously thought – a discovery that will transform thinking on treatment for people living with rheumatic heart disease (RHD).